Zobrazeno 1 - 10
of 2 668
pro vyhledávání: '"Maria A. Lopez"'
Autor:
Pankti Reid, Sabina Sandigursky, Juhee Song, Maria A. Lopez-Olivo, Houssein Safa, Samuel Cytryn, Elizaveta Efuni, Maryam Buni, Anna Pavlick, Michelle Krogsgaard, Osama Abu-Shawer, Mehmet Altan, Jeffrey S. Weber, Osama E. Rahma, Maria E. Suarez-Almazor, Adi Diab, Noha Abdel-Wahab
Publikováno v:
OncoImmunology, Vol 12, Iss 1 (2023)
ABSTRACTPatients with preexisting autoimmune disease (pAID) are generally excluded from clinical trials for immune checkpoint inhibitors (ICIs) for cancer due to concern of flaring pAID. In this multi-center, retrospective observational study, we com
Externí odkaz:
https://doaj.org/article/e9e4bf95dfc442469304d1d2730ac304
Publikováno v:
Journal of Immunotherapy and Precision Oncology, Vol 6, Iss 2, Pp 103-110 (2023)
Introduction: Immune checkpoint inhibitors (ICIs) can cause inflammatory and immune-related adverse events (irAEs) that might worsen the course of COVID-19. We conducted a systematic review (PROSPERO ID: CRD42022307545) to evaluate the clinical cours
Externí odkaz:
https://doaj.org/article/b99cf3be836548e296b05d81c0830c60
Publikováno v:
Exploratory Research in Clinical and Social Pharmacy, Vol 11, Iss , Pp 100317- (2023)
Objectives: Machine learning algorithms are being increasingly used for predicting hospital readmissions. This meta-analysis evaluated the performance of logistic regression (LR) and machine learning (ML) models for the prediction of 30-day hospital
Externí odkaz:
https://doaj.org/article/af73eb14aeb1465a8ced1dbd2a70b4f4
Autor:
Christopher J. Hanley, Sara Waise, Matthew J. Ellis, Maria A. Lopez, Wai Y. Pun, Julian Taylor, Rachel Parker, Lucy M. Kimbley, Serena J. Chee, Emily C. Shaw, Jonathan West, Aiman Alzetani, Edwin Woo, Christian H. Ottensmeier, Matthew J. J. Rose-Zerilli, Gareth J. Thomas
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-18 (2023)
Fibroblast heterogeneity is a prominent but poorly understood feature of solid tumours. Here three major fibroblast subpopulations in non-small cell lung cancer are identified and characterised through single cell RNA-sequencing, multiplexed immunohi
Externí odkaz:
https://doaj.org/article/90c9737e349b4a0f860180335c1700ab
Autor:
Naomi Q. P. Tan, Shawn P. E. Nishi, Lisa M. Lowenstein, Tito R. Mendoza, Maria A. Lopez‐Olivo, Laura C. Crocker, Karen R. Sepucha, Robert J. Volk
Publikováno v:
Cancer Medicine, Vol 11, Iss 3, Pp 790-797 (2022)
Abstract Background Professional organizations recommend the use of shared decision‐making (SDM) in supporting patients’ decisions about lung cancer screening (LCS). The objective of this study was to assess the impact of the SDM process on patie
Externí odkaz:
https://doaj.org/article/3f1dae9fcf5b4ea294ad6f65bd296d1b
Autor:
Maria A. Lopez-Olivo, Johncy J. Kachira, Maryam Buni, Sang Taek Kim, Huifang Lu, Jean H. Tayar, Gabrielle F. Duhon, Juan I. Ruiz, Clifton O. Bingham, Cassandra Calabrese, Robert J. Volk, Maria E. Suarez-Almazor
Publikováno v:
Cancers, Vol 15, Iss 15, p 4004 (2023)
Patients with pre-existing autoimmune disorders and cancer considering immune checkpoint inhibitors (ICIs) need to receive balanced information about the benefits and risk of developing immune-related adverse events (irAEs) and flare-ups of their aut
Externí odkaz:
https://doaj.org/article/cc84efd0a6ea4c299207a69fc71aeb7c
Autor:
Lama H. Nazer, PharmD, FCCM, Maria A. Lopez-Olivo, MD, PhD, Anne Rain Brown, PharmD, FCCM, John A. Cuenca, MD, Michael Sirimaturos, PharmD, FCCM, Khader Habash, PharmD, Nada AlQadheeb, PharmD, Heather May, PharmD, Victoria Milano, PharmD, Amy Taylor, Joseph L. Nates, MD, MBA, MCCM
Publikováno v:
Critical Care Explorations, Vol 4, Iss 9, p e0757 (2022)
OBJECTIVES:. The reported mortality rates of cancer patients admitted to ICUs vary widely. In addition, there are no studies that examined the outcomes of critically ill cancer patients based on the geographical regions. Therefore, we aimed to evalua
Externí odkaz:
https://doaj.org/article/cb7f491e78da44fdbeb7d4f092b6bdeb
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
We reviewed the available information on the use of immune checkpoint inhibitors (ICIs) in populations with special conditions, namely, patients with HIV, tuberculosis, or underlying autoimmune disease. Available data show that treatment with ICIs is
Externí odkaz:
https://doaj.org/article/1b8d1e5699ce4d34960e3bd4892aa839
Autor:
Maria A. Lopez-Olivo, Gabrielle F. Duhon, Juan I. Ruiz, Mehmet Altan, Hussein Tawbi, Adi Diab, Clifton O. Bingham, Cassandra Calabrese, Natalia I. Heredia, Robert J. Volk, Maria E. Suarez-Almazor
Publikováno v:
Cancers, Vol 15, Iss 10, p 2690 (2023)
Immune checkpoint inhibitors (ICIs) have improved cancer outcomes but can cause severe immune-related adverse events (irAEs) and flares of autoimmune conditions in cancer patients with pre-existing autoimmune disease. The objective of this study was
Externí odkaz:
https://doaj.org/article/c9bce1ccb93e4e38af447a2a0ff8965d
Autor:
Maria A. Lopez‐Olivo, Jude K. des Bordes, Heather Lin, Robert J. Volk, Tara Rizvi, Maria E. Suarez‐Almazor
Publikováno v:
ACR Open Rheumatology, Vol 3, Iss 3, Pp 185-195 (2021)
Objective The objective of this study was to assess the efficacy of self‐administered patient educational tools in improving knowledge and behaviors for the management of knee osteoarthritis. Methods We conducted a randomized clinical trial in pati
Externí odkaz:
https://doaj.org/article/93f621678173480b8aa4e72474249110